Saturday, October 12, 2024
HomeFinanceBMO Capital Markets says this biotech company is 'best-in-class,' sees shares surging...

BMO Capital Markets says this biotech company is ‘best-in-class,’ sees shares surging more than 25%




This story originally appeared on CNBC

RELATED ARTICLES
- Advertisment -

Most Popular

Recent Comments